DYNAMIC WEALTH RESEARCH
  • Stock Market
  • Hard Assets
  • Clean Tech
  • Tech
  • Crypto
  • Cannabis
  • Psychedelics
  • About
    • Contact
  •  
  •  
  •  

Psychedelic Stocks

 Psychedelic Stocks Home

atai Life Sciences Reports Second Quarter 2022 Financial Results & Business Update

Atai reports its Q2 2022 results, announces a new $175 million loan facility and streamlines its operations.

08/15/2022 PSW Editor

MindMed Board of Directors Approves Reverse Share Split

Mind Medicine announces a reverse share split of its common shares at a 1-15 ratio. Exchange symbols will remain the same but new CUSIP numbers will be assigned by the appropriate regulators.

08/05/2022 PSW Editor

COMPASS Pathways plc announces second quarter 2022 financial results and business highlights

Compass Pathways reports its Q2 2022 results. Preparing for its Phase 3 clinical trial for TRD. Net loss of $21.0 million. Cash (and equivalents) of $207.2 million.

08/04/2022 PSW Editor

BetterLife Secures Additional Mitacs Funding in Collaboration with Carleton University Research Team for BETR-001 Preclinical Depression Studies

Better Life Pharma announces additional funding to study BETR-001 as a treatment for depression, via the Mitacs Accelerate program.

07/06/2022 PSW Editor

Red Light Holland and Superstar Wiz Khalifa to Launch Naturally Occurring Psilocybin and Mushrooms Wellness Brand: Mistercap

Red Light Holland announces a partnership with platinum-selling rapper, Wiz Khalifa, to launch Red Light Holland's MISTERCAP brand of psilocybin-based products.

06/30/2022 PSW Editor

Cybin Receives FDA IND Clearance for its Phase 1/2a Clinical Trial Evaluating CYB003 for the Potential Treatment of Major Depressive Disorder

Cybin announces receipt of its "may proceed letter" from the U.S. Food and Drug Administration (FDA) regarding its Phase 1/2a clinical trial of CYB003 for major depressive disorder (MDD).

06/27/2022 PSW Editor

Numinus Pilots Mental Health Program for Corporate Clients in Utah

Numinus announces a pilot program to encourage employers to offer ketamine-assisted psychotherapy to employees as a health benefit.

06/23/2022 PSW Editor

Cybin Inc. Reports Fiscal Year 2022 Financial Results and Recent Business Highlights

Cybin Inc reports its fiscal year 2022 financial results, including progress on several pipeline initiatives, with a cash balance of CAD$53.6 million as of March 31, 2022.

06/23/2022 PSW Editor

BetterLife To Present BETR-001 Preclinical Data at the Upcoming Federation of European Neuroscience Societies (FENS) Forum

Better Life Pharma will be presenting an abstract on its lead compound, BETR-001, to the European Neuroscience Societies (FENS) Forum in July.

06/21/2022 PSW Editor

Optimi Health Requests Approval To Manufacture MDMA, Other Synthetic Psychedelics

Optimi files an application with Health Canada to synthesize, process and produce pharmaceutical grade 3,4-Methylenedioxymethamphetamine ("MDMA").

06/20/2022 PSW Editor

Numinus completes acquisition of Novamind and announces executive appointments

Numinus Wellness announces the completion of its acquisition of Novamind Inc, with Novamind shareholders receiving 0.84 shares of Numinus per Novamind share.

06/13/2022 PSW Editor

Cybin Acquires DMT Clinical Study from Entheon Biomedical

Cybin Inc announces acquiring a Phase 1 DMT study from Entheon Biomedical, at a purchase price of CAD$1 million plus additional considerations.

06/07/2022 PSW Editor
  • 1
  • 2
  • 3
  • 4
  • ...
  • 72
  • Next

Exclusives

Responsive image
Visible Gold At Depth For Rua Gold As Momentum Builds

New drill results from Rua Gold's Reefton Goldfield Project include a high-grade gold intercept with visible gold in the core sample.


The Silver Short Squeeze: A Historic Market Battle in the Making

Gold stocks’ winter rally 2024

Warren Buffett's Berkshire Hathaway Sells Apple Stock, Boosts Cash Pile to Record

The stock market gives this candidate a 70% chance to be the next U.S. president

SHARE DYNAMIC WEALTH RESEARCH

Our Mission

Learn More


  • About
  • Contact

Contact Us


info@dynamicwealthresearch.org
Sandstone Media, LLC.
2010 West Avenue K #623 Lancaster, CA 93536

Subscribe to Newsletter

Stay informed on new causes and upcoming organization updates. Don't miss things!

By providing your e-mail, you are consenting to receive press releases and other information concerning Psychedelic Stock Watch and its affiliates and partners. You may withdraw your consent at any time.

UNSUBSCRIBE
© 2016 - 2025 DYNAMIC WEALTH RESEARCH, Privacy Policy, Disclaimer
powered by structure cms™